Newsroom

Title
KIRO-TV: EvergreenHealth tests coronavirus drug, remdesivir
Date
04/30/2020
Article

EvergreenHealth will enter the second arm of the clinical trial for remdesivir after positive results. EvergreenHealth treated patients with the most severe symptoms, some on ventilators, with the drug that was developed for Ebola. 

Dr. Diego Lopez de Castilla is the lead investigator of the trial and told KIRO-7 that the treatment is a game-changer.

Click to watch the KIRO-TV report >